Study Stopped
Inability to recruit subjects
Functional and Quality of Life Outcomes Following Viscosupplementation for Knee Osteoarthritis
1 other identifier
observational
43
1 country
1
Brief Summary
This study will compare changes in outcomes following viscosupplementation for knee osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 29, 2011
CompletedFirst Posted
Study publicly available on registry
October 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedJanuary 27, 2014
January 1, 2014
4.3 years
September 29, 2011
January 24, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
The (WOMAC) Index is a multidimensional, self-administered health status instrument for patients with osteoarthritis of the hip or knee. The index is a disease-specific, purpose built, high performance instrument for evaluative research in osteoarthritis clinical trials.
Decsribes any change from baseline over a period of 12 months; the study subjects will complete the (WOMAC) Index at baseline, 1, 3, 6 and 12 months following the viscosupplementation of the knee.
Secondary Outcomes (6)
Visual Analog Scale (VAS) documentation of the level of knee pain. The (VAS) will describe the change in the level of knee pain from baseline following viscosupplementation of the knee.
The study subjects will complete the (VAS) at baseline, 1, 3, 6 and 12 months following the viscosupplementation of the knee.
Medical Outcomes Short Form (SF-36); completed to describe any change in perceived Quality of Life (QOL) from baseline following viscosupplementation of the knee.
The study subjects will complete the (SF-36) at baseline, 1, 3, 6 and 12 mos. following viscosupplementation of the knee.
Chair Rise Time; describes any change from baseline in time to rise from a chair following viscosupplementation of the knee
The study subjects will complete the chair rise at baseline, 1, 3,6 and 12 mos. following viscosupplementation of the knee.
Stair Climb Time; describes any change in the time from baseline to walk up a flight of 12 steps following viscosupplementation of the knee
The study subjects will complete the stair climb at baseline, 1, 3, 6 and 12 mos. following viscosupplementation of the knee.
Six Minute Walk Test; describes any change from baseline in leg pain following viscosupplementation of the knee.
The study subjects will complete the six minute walk test at baseline, 1, 3, 6 and 12 mos. following viscosupplementation of the knee.
- +1 more secondary outcomes
Study Arms (1)
Outcomes following viscosupplemantation
Patients with documented knee osteoarthritis receiving viscosupplementation of the knee.
Interventions
The study subject outcomes (WOMAC, VAS, SF-36, Chair rise, Stair climb, Six minute walk and Gait analysis) measured at 1, 3, 6 and 12 months following viscosupplementation of the knee
Eligibility Criteria
Patients with symptomatic knee osteoarthritis.
You may qualify if:
- years of age or older
- osteoarthritis degeneration, degenerative joint disease or degeneration
- fully cognizant of study procedures
- willing to carefully participate in all study processes and assessments
You may not qualify if:
- less that 21 years of age
- allergic reactivity to hyaluronic acid
- current knee infection, infection around injection site or any skin disease
- pregnancy or lactation
- non-ambulatory
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UF&Shands Orthopaedics and Sports Medicine Institute
Gainesville, Florida, 32607, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather K Vincent, Ph.D.
University of Florida Department of Orthopaedics and Rehabilitation
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2011
First Posted
October 6, 2011
Study Start
August 1, 2009
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
January 27, 2014
Record last verified: 2014-01